{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:53:54Z","timestamp":1770288834694,"version":"3.49.0"},"reference-count":41,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.3892\/ijo.2012.1734","type":"journal-article","created":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T07:54:11Z","timestamp":1355298851000},"page":"741-748","source":"Crossref","is-referenced-by-count":6,"title":["Oral or parenteral administration of curcumin does not prevent the growth of high-risk t(4;11) acute lymphoblastic leukemia cells engrafted into a NOD\/SCID mouse model"],"prefix":"10.3892","volume":"42","author":[{"given":"SUSAN J.","family":"ZUNINO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DAVID H.","family":"STORMS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOHN W.","family":"NEWMAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"THERESA L.","family":"PEDERSEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CARL L.","family":"KEEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JONATHAN M.","family":"DUCORE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2012,12,12]]},"reference":[{"key":"key20180107181129_b1-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tips.2008.11.002","article-title":"Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets","volume":"30","author":"Aggarwal","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"key20180107181129_b2-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/01635581.2012.630551","article-title":"Cancer cell signaling pathways targeted by spice-derived nutraceuticals","volume":"64","author":"Sung","year":"2012","journal-title":"Nutr Cancer"},{"key":"key20180107181129_b3-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ardp.200900319","article-title":"Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials","volume":"343","author":"Shehzad","year":"2010","journal-title":"Arch Pharm (Weinheim)"},{"key":"key20180107181129_b4-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0090-9556(24)15211-7","article-title":"Biotransformation of curcumin through reduction and glucuronidation in mice","volume":"27","author":"Pan","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"key20180107181129_b5-ijo-42-02-0741","first-page":"1058","article-title":"Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production","volume":"61","author":"Ireson","year":"2001","journal-title":"Cancer Res"},{"key":"key20180107181129_b6-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/carcin\/13.11.2183","article-title":"Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene","volume":"13","author":"Huang","year":"1992","journal-title":"Carcinogenesis"},{"key":"key20180107181129_b7-ijo-42-02-0741","first-page":"5941","article-title":"Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate","volume":"48","author":"Huang","year":"1988","journal-title":"Cancer Res"},{"key":"key20180107181129_b8-ijo-42-02-0741","first-page":"5841","article-title":"Inhibitory effects of dietary curcumin on fore-stomach, duodenal, and colon carcinogenesis in mice","volume":"54","author":"Huang","year":"1994","journal-title":"Cancer Res"},{"key":"key20180107181129_b9-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/carcin\/21.10.1835","article-title":"Potent preventive action of curcumin on radiation-induced initiation of mammary tumorigenesis in rats","volume":"21","author":"Inano","year":"2000","journal-title":"Carcinogenesis"},{"key":"key20180107181129_b10-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/carcin\/20.6.1011","article-title":"Chemoprevention by curcumin during the promotion stage of tumorigenesis of mammary gland in rats irradiated with \u03b3-rays","volume":"20","author":"Inano","year":"1999","journal-title":"Carcinogenesis"},{"key":"key20180107181129_b11-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/carcin\/21.2.331","article-title":"Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis","volume":"21","author":"Chuang","year":"2000","journal-title":"Carcinogenesis"},{"key":"key20180107181129_b12-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"7490","DOI":"10.1158\/1078-0432.CCR-05-1192","article-title":"Curcumin suppresses the paclitaxel-induced nuclear factor-\u03baB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice","volume":"11","author":"Aggarwal","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key20180107181129_b13-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000099202","article-title":"The chemopreventive polyphenol curcumin prevents hematogenous breast cancer metastases in immunodeficient mice","volume":"19","author":"Bachmeier","year":"2007","journal-title":"Cell Physiol Biochem"},{"key":"key20180107181129_b14-ijo-42-02-0741","first-page":"275","article-title":"Inhibition of progression of erythroleukemia induced by Friend virus in BALB\/c mice by natural products - berberine, curcumin and picroliv","volume":"7","author":"Harikumar","year":"2008","journal-title":"J Exp Ther Oncol"},{"key":"key20180107181129_b15-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1179\/102453308X343437","article-title":"Curcumin inhibits proliferation and induces apoptosis of leukemic cells expressing wild-type or T315I-BCR-ABL and prolongs survival of mice with acute lymphoblastic leukemia","volume":"13","author":"William","year":"2008","journal-title":"Hematol"},{"key":"key20180107181129_b16-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1182\/blood.V91.11.3995","article-title":"Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia","volume":"91","author":"Faderl","year":"1998","journal-title":"Blood"},{"key":"key20180107181129_b17-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrc1164","article-title":"Origins of chromosome translocations in childhood leukaemia","volume":"3","author":"Greaves","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"key20180107181129_b18-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.1994.tb04726.x","article-title":"The acute lymphoblastic leukaemia cell line SEM with t(4;11) chromosomal rearrangement is biphenotypic and responsive to interleukin-7","volume":"86","author":"Greil","year":"1994","journal-title":"Br J Haematol"},{"key":"key20180107181129_b19-ijo-42-02-0741","first-page":"1277","article-title":"Resveratrol given intraperitoneally does not inhibit the growth of high-risk t(4;11) acute lymphoblastic leukemia cells in a NOD\/SCID mouse model","volume":"40","author":"Zunino","year":"2012","journal-title":"Int J Oncol"},{"key":"key20180107181129_b20-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1182\/blood.V99.11.4100","article-title":"The nonobese diabetic\/severe combined immunodeficient (NOD\/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse","volume":"99","author":"Lock","year":"2002","journal-title":"Blood"},{"key":"key20180107181129_b21-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1182\/blood-2003-08-2911","article-title":"Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies","volume":"103","author":"Liem","year":"2004","journal-title":"Blood"},{"key":"key20180107181129_b22-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1111\/j.1523-1755.2005.00658.x","article-title":"Curcumin blocks fibrosis in anti-Thy 1 glomerulonephritis through up-regulation of heme oxygenase 1","volume":"68","author":"Gaedeke","year":"2005","journal-title":"Kidney Int"},{"key":"key20180107181129_b23-ijo-42-02-0741","unstructured":"United States Department of Health and Human Services, Food and Drug AdministrationCenter for Veterinary Medicine: Guidance for Industry Validation of Analytical Procedures for Type C Medicated Feeds. #1351142005http:\/\/www.fda.gov\/downloads\/AnimalVeterinary\/GuidanceComplianceEnforcement\/GuidanceforIndustry\/ucm052530.pdf"},{"key":"key20180107181129_b24-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.3892\/ijo.2012.1650","article-title":"Dietary resveratrol does not delay engraftment, sensitize to vincristine or inhibit growth of high-risk acute lymphoblastic leukemia cells in NOD\/SCID mice","volume":"41","author":"Zunino","year":"2012","journal-title":"Int J Oncol"},{"key":"key20180107181129_b25-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1158\/1078-0432.CCR-04-0744","article-title":"Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance","volume":"10","author":"Sharma","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20180107181129_b26-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.ejca.2005.05.009","article-title":"Curcumin: the story so far","volume":"41","author":"Sharma","year":"2005","journal-title":"Eur J Cancer"},{"key":"key20180107181129_b27-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1472-6882-6-10","article-title":"Dose escalation of a curcuminoid formulation","volume":"6","author":"Lao","year":"2006","journal-title":"BMC Complement Altern Med"},{"key":"key20180107181129_b28-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0300-483X(81)90027-5","article-title":"Metabolism of curcumin - studies with [3H] curcumin","volume":"22","author":"Ravindranath","year":"1982","journal-title":"Toxicol"},{"key":"key20180107181129_b29-ijo-42-02-0741","first-page":"2895","article-title":"Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or premalignant lesions","volume":"21","author":"Cheng","year":"2001","journal-title":"Anticancer Res"},{"key":"key20180107181129_b30-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1158\/1055-9965.EPI-07-2693","article-title":"Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects","volume":"17","author":"Vareed","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20180107181129_b31-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1158\/1940-6207.CAPR-10-0098","article-title":"Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia","volume":"4","author":"Carroll","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"key20180107181129_b32-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.cgh.2006.08.008","article-title":"Curcumin maintenance therapy for ulcerative colitis: randomized, mulicenter, double-blind, placebo-controlled trial","volume":"4","author":"Hanai","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20180107181129_b33-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-08-0024","article-title":"Phase II trial of curcumin in patients with advanced pancreatic cancer","volume":"14","author":"Dhillon","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20180107181129_b34-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.drudis.2011.09.009","article-title":"Curcumin nanoformulations: a future nanomedicine for cancer","volume":"17","author":"Yallapu","year":"2012","journal-title":"Drug Discov Today"},{"key":"key20180107181129_b35-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.1021\/jf202135j","article-title":"PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms","volume":"59","author":"Xie","year":"2011","journal-title":"J Agric Food Chem"},{"key":"key20180107181129_b36-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00280-011-1749-y","article-title":"Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice","volume":"69","author":"Zhongfa","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107181129_b37-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/01635581.2010.509835","article-title":"Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs","volume":"62","author":"Goel","year":"2010","journal-title":"Nutr Cancer"},{"key":"key20180107181129_b38-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1038\/onc.2011.23","article-title":"Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer","volume":"30","author":"Sreekanth","year":"2011","journal-title":"Oncogene"},{"key":"key20180107181129_b39-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1002\/jps.22157","article-title":"Curcumin enhances oral bioavailability and anti-tumor therapeutic efficacy of paclitaxel upon administration in nanoemulsion formulation","volume":"99","author":"Ganta","year":"2010","journal-title":"J Pharm Sci"},{"key":"key20180107181129_b40-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.canlet.2010.03.017","article-title":"Novel in vivo model of inducible multi-drug resistance in acute lymphoblastic leukemia with chromosomal translocation t(4;11)","volume":"296","author":"Zunino","year":"2010","journal-title":"Cancer Lett"},{"key":"key20180107181129_b41-ijo-42-02-0741","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJM199806043382304","article-title":"Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy","volume":"338","author":"Nachman","year":"1998","journal-title":"N Engl J Med"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2012.1734\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T14:58:45Z","timestamp":1745420325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2012.1734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,12]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,12,12]]},"published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.3892\/ijo.2012.1734"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2012.1734","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,12]]}}}